Medtronic reports third quarter fiscal 2022 financial results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Medtronic, Inc. (MDT) PT Lowered to $124 at Needham & Company
February 22, 2022 1:59 PM ESTNeedham & Company analyst Michael Matson lowered the price target on Medtronic, Inc. (NYSE: MDT) to $124.00 (from $128.00) while maintaining a Buy rating following earnings.
The analyst commented, "MDT's F3Q22 revenue missed consensus while its EPS beat consensus and organic revenue growth slowed... More
Medtronic (MDT) Reports In-Line Q3 EPS; Guides Q4 In-Line
February 22, 2022 6:46 AM ESTMedtronic (NYSE: MDT) reported Q3 EPS of $1.37, in-line with the analyst estimate of $1.37. Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.94 billion.
GUIDANCE:
Medtronic sees Q4 2022 EPS of $1.56-$1.58, versus the consensus of $1.58. The company... More
